Practical Considerations for the Nonvitamin K Antagonist Oral Anticoagulants

Publisher： Karger

E-ISSN： 1421-9751|136|2|115-124

ISSN： 0008-6312

Source： Cardiology, Vol.136, Iss.2, 2016-09, pp. : 115-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 11-12, 2015-12 ,pp. : 1239-1249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1341-1348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of renal failure with the non‐vitamin K antagonist oral anticoagulants: systematic review and meta‐analysis

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 7, 2015-07 ,pp. : 757-764

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1192-1200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of prothrombin complex concentrate administration and hematoma enlargement in non–vitamin K antagonist oral anticoagulant–related intracerebral hemorrhage

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 1, 2018-01 ,pp. : 186-196

John Wiley & Sons Inc

Access to resources Recommend Favorite